These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15353528)

  • 1. Staging for antiretroviral therapy among HIV-infected drug users.
    Wood E; Hogg RS; Bonner S; Kerr T; Li K; Palepu A; Guillemi S; Schechter MT; Montaner JS
    JAMA; 2004 Sep; 292(10):1175-7. PubMed ID: 15353528
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users.
    Tun W; Gange SJ; Vlahov D; Strathdee SA; Celentano DD
    Clin Infect Dis; 2004 Apr; 38(8):1167-74. PubMed ID: 15095224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
    Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
    HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
    Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
    Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
    Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use.
    Dronda F; Zamora J; Moreno S; Moreno A; Casado JL; Muriel A; Pérez-Elías MJ; Antela A; Moreno L; Quereda C
    AIDS; 2004 Nov; 18(16):2210-2. PubMed ID: 15577659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality among urban drug users and the impact of highly active antiretroviral therapy.
    Celentano DD
    Clin Infect Dis; 2005 Sep; 41(6):873-4. PubMed ID: 16107988
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy.
    Yacisin K; Maida I; Ríos MJ; Soriano V; Núñez M
    AIDS Res Hum Retroviruses; 2008 Jul; 24(7):935-40. PubMed ID: 18593347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter.
    Wu CJ; Lee HC; Yang YL; Chang CM; Chen HT; Lin CC; Lee NY; Chu WL; Hsieh LY; Wang YL; Lauderale TL; Tseng FC; Ko NY; Ko WC; Lo HJ
    Clin Microbiol Infect; 2012 May; 18(5):485-90. PubMed ID: 21939471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy.
    Ing EC; Bae JW; Maru DS; Altice FL
    AIDS Behav; 2013 Jan; 17(1):113-21. PubMed ID: 22105340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunovirologic characteristics of human immunodeficiency virus-infected patients consisting mainly of injecting drug users on highly active antiretroviral treatment with prolonged virologic failure.
    Vallejo A; Ruiz-Mateos E; Molina-Pinelo S; Soriano-Sarabia N; de Felipe B; Gutierrez S; Sánchez-Quijano A; Lissen E; Leal M
    Viral Immunol; 2006; 19(4):759-67. PubMed ID: 17201671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving survival among HIV-infected injection drug users: how should we define success?
    Kirk GD; Vlahov D
    Clin Infect Dis; 2007 Aug; 45(3):377-80. PubMed ID: 17599318
    [No Abstract]   [Full Text] [Related]  

  • 14. Current perspectives in HIV therapeutics.
    Okulicz JF
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):12-3. PubMed ID: 21704879
    [No Abstract]   [Full Text] [Related]  

  • 15. Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users.
    Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
    Antivir Ther; 2004 Apr; 9(2):229-35. PubMed ID: 15134185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual risk behavior in HIV-infected injection drug users.
    Battegay M; Bucher HC; Vernazza P
    Clin Infect Dis; 2004 Apr; 38(8):1175-7. PubMed ID: 15095225
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study.
    Rasmussen LD; Dybdal M; Gerstoft J; Kronborg G; Larsen CS; Pedersen C; Pedersen G; Jensen J; Pedersen L; Sørensen HT; Obel N
    HIV Med; 2011 Apr; 12(4):202-10. PubMed ID: 20726905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coinfection with HIV and hepatitis C virus and immune restoration during HAART.
    Manfredi R
    Clin Infect Dis; 2006 Jan; 42(2):298-9. PubMed ID: 16355345
    [No Abstract]   [Full Text] [Related]  

  • 19. CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.
    Okulicz JF; Grandits GA; Weintrob AC; Landrum ML; Ganesan A; Crum-Cianflone NF; Agan BK; Marconi VC
    Clin Infect Dis; 2010 Apr; 50(8):1187-91. PubMed ID: 20218878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.
    Okano A; Matsuda M; Chiba T; Moriya K; Yamada K; Sugiura W
    Jpn J Infect Dis; 2002 Apr; 55(2):62-5. PubMed ID: 12082315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.